|
|
||||||||
Review Articles |
Isozymes of alcohol and other dehydrogenases convert ethanol and retinol to their corresponding aldehydes in vitro. In addition, new pathways of retinol metabolism have been described in hepatic microsomes that involve, in part, cytochrome P450s, which can also metabolize various drugs. In view of these overlapping metabolic pathways, it is not surprising that multiple interactions between retinol, ethanol, and other drugs occur. Accordingly, prolonged use of alcohol, drugs, or both, results not only in decreased dietary intake of retinoids and carotenoids, but also accelerates the breakdown of retinol through cross-induction of degradative enzymes. There is also competition between ethanol and retinoic acid precursors. Depletion ensues, with associated hepatic and extrahepatic pathology, including carcinogenesis and contribution to fetal defects. Correction of deficiency through vitamin A supplementation has been advocated. It is, however, complicated by the intrinsic hepatotoxicity of retinol, which is potentiated by concomitant alcohol consumption. By contrast, ß-carotene, a precursor of vitamin A, was considered innocuous until recently, when it was found to also interact with ethanol, which interferes with its conversion to retinol. Furthermore, the combination of ß-carotene with ethanol results in hepatotoxicity. Moreover, in smokers who also consume alcohol, ß-carotene supplementation promotes pulmonary cancer and, possibly, cardiovascular complications. Experimentally, ß-carotene toxicity was exacerbated when administered as part of beadlets. Thus ethanol, while promoting a deficiency of vitamin A also enhances its toxicity as well as that of ß-carotene. This narrowing of the therapeutic window for retinol and ß-carotene must be taken into account when formulating treatments aimed at correcting vitamin A deficiency, especially in drinking populations.
Key Words: Ethanol alcohol retinol retinoids ß-carotene carotenoids pulmonary cancer vitamin A beadlets liver cardiovascular complications carcinogenicity hepatotoxicity fetal alcohol syndrome Carotene and Retinol Efficacy Trial CARET Alpha-Tocopherol, Beta-Carotene and Cancer Prevention Study ATBC review
This article has been cited by other articles:
![]() |
S. Veeramachaneni, L. M. Ausman, S. W. Choi, R. M. Russell, and X.-D. Wang High Dose Lycopene Supplementation Increases Hepatic Cytochrome P4502E1 Protein and Inflammation in Alcohol-Fed Rats J. Nutr., July 1, 2008; 138(7): 1329 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tynes and T. Haldorsen Mortality in the Sami population of North Norway, 1970--98 Scand J Public Health, May 1, 2007; 35(3): 306 - 312. [Abstract] [PDF] |
||||
![]() |
O. Ziouzenkova, G. Orasanu, G. Sukhova, E. Lau, J. P. Berger, G. Tang, N. I. Krinsky, G. G. Dolnikowski, and J. Plutzky Asymmetric Cleavage of {beta}-Carotene Yields a Transcriptional Repressor of Retinoid X Receptor and Peroxisome Proliferator-Activated Receptor Responses Mol. Endocrinol., January 1, 2007; 21(1): 77 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Preston, G. Tang, J. U. Tilan, N. S. Hill, and Y. J. Suzuki Retinoids and Pulmonary Hypertension Circulation, February 15, 2005; 111(6): 782 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Poschl and H. K. Seitz ALCOHOL AND CANCER Alcohol Alcohol., May 1, 2004; 39(3): 155 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.J. Alija, N. Bresgen, O. Sommerburg, W. Siems, and P.M. Eckl Cytotoxic and genotoxic effects of {beta}-carotene breakdown products on primary rat hepatocytes Carcinogenesis, May 1, 2004; 25(5): 827 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Baron, B. F. Cole, L. Mott, R. Haile, M. Grau, T. R. Church, G. J. Beck, and E. R. Greenberg Neoplastic and Antineoplastic Effects of {beta}-Carotene on Colorectal Adenoma Recurrence: Results of a Randomized Trial J Natl Cancer Inst, May 21, 2003; 95(10): 717 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Michaelsson, H. Lithell, B. Vessby, and H. Melhus Serum Retinol Levels and the Risk of Fracture N. Engl. J. Med., January 23, 2003; 348(4): 287 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-D. Wang Retinoids and Alcohol-Related Carcinogenesis J. Nutr., January 1, 2003; 133(1): 287S - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Stickel, D Schuppan, E G Hahn, and H K Seitz Cocarcinogenic effects of alcohol in hepatocarcinogenesis Gut, July 1, 2002; 51(1): 132 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Molotkov and G. Duester Retinol/Ethanol Drug Interaction during Acute Alcohol Intoxication in Mice Involves Inhibition of Retinol Metabolism to Retinoic Acid by Alcohol Dehydrogenase J. Biol. Chem., June 14, 2002; 277(25): 22553 - 22557. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Blanchon, P. Sauvant, C. Bavik, D. Gallot, F. Charbonne, M.-C. Alexandre-Gouabau, D. Lemery, B. Jacquetin, B. Dastugue, S. Ward, et al. Human choriocarcinoma cell line JEG-3 produces and secretes active retinoids from retinol Mol. Hum. Reprod., May 1, 2002; 8(5): 485 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Denke Dietary Retinol--A Double-edged Sword JAMA, January 2, 2002; 287(1): 102 - 104. [Full Text] [PDF] |
||||
![]() |
E. V. Bandera, J. L. Freudenheim, and J. E. Vena Alcohol Consumption and Lung Cancer: A Review of the Epidemiologic Evidence Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 813 - 821. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ni, M. A. Leo, J. Zhao, and C. S. Lieber Toxicity of {beta}-carotene and its exacerbation by acetaldehyde in HepG2 cells Alcohol Alcohol., July 1, 2001; 36(4): 281 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
H K SEITZ Alcohol and retinoid metabolism Gut, December 1, 2000; 47(6): 748 - 750. [Full Text] [PDF] |
||||
![]() |
J. M. Miano and B. C. Berk Retinoids : Versatile Biological Response Modifiers of Vascular Smooth Muscle Phenotype Circ. Res., September 1, 2000; 87(5): 355 - 362. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |